INTERNATIONAL PATENT: SUMMIT THERAPEUTICS INC. FILES APPLICATION FOR "KRAS G12D MUTATION TARGETING COMPOUNDS"

GENEVA, April 8 -- SUMMIT THERAPEUTICS INC. (2882 Sand Hill RoadSuite 106Menlo Park, California 94025) filed a patent application (PCT/US2024/048875) for "KRAS G12D MUTATION TARGETING COMPOUNDS" on Sep 27, 2024. With publication no. WO/2025/072686, the details related to the patent application was published on Apr 03, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ZANALETTI, Riccardo (c/o Summit Therapeutics Inc.2882 Sand Hill Road, Suite 106Menlo Park, California 94025), KHAN, Mohammed Nawaz (c/o Summit Therapeutics Inc.2882 Sand Hill Road, Suite 106Menlo Park, California 94025), CHANG, Be...